Literature DB >> 20383168

Expression of a dominant-negative Rho-kinase promotes neurite outgrowth in a microenvironment mimicking injured central nervous system.

Ping Yang1, Hui-zhong Wen, Jin-hai Zhang.   

Abstract

AIM: To investigate whether lentiviral vector (LV)-mediated expression of a dominant negative mutant Rho-kinase (DNROCK) could inhibit activation of the Rho/ROCK signaling pathway and promote neurite outgrowth in a hostile microenvironment mimicking the injured central nervous system (CNS) in vitro.
METHODS: Lentiviral stock was produced using the three-plasmid system by transfecting HEK293 cells. Myelin prepared from rat brain was purified by two rounds of discontinuous density gradient centrifugation and osmotic disintegration. Differentiated PC12 cells and dissociated adult rat dorsal root ganglion (DRG) neurons were transduced with either LV/DNROCK or LV/green fluorescent protein (GFP) and seeded on solubilized myelin proteins. The effect of DNROCK on growth cone morphology was tested by rhodamine-conjugated phalloidin staining. Expression of DNROCK was determined by immunoblotting. The length of the longest neurite, the percentage of neurite-bearing neurons, or the total process outgrowth for all transduced neurons were measured by using the Scion image analysis program.
RESULTS: Transduction of DNROCK inhibited serum-induced stress fiber formation in NIH 3T3 cells and induced enlargement of cell bodies and decreased the phosphorylation levels of MYPT1 in HeLa cells. LV/DNROCK blocked myelin-induced increase in ROCK translocation from cytosol to membrane in LV/GFP-treated PC12 cells. DNROCK promotes neurite outgrowth of differentiated PC12 cells and DRG neurons on myelin protein. LV/DNROCK-transduced PC12 cells had longer neurites than LV/GFP-transduced cells (39.18+/-2.19 microm vs 29.32+/-1.7 microm, P<0.01) on myelin-coated coverslips. Furthermore, a significantly higher percentage of LV/DNROCK-transduced cells had extended neurites than LV/GFP-transduced cells (63.75%+/-8.03% vs 16.3%+/-3.70%, P<0.01). LV/DNROCK-transduced DRG neurons had longer neurite length (325.22+/-10.8 microm vs 202.47+/-9.3 microm, P<0.01) and more primary neurites per cell than those in LV/GFP-transduced cells plated on myelin and laminin (7.8+/-1.25 vs 4.84+/-1.45, P<0.01) or on laminin alone (5.2+/-1.88). LV/DNROCK-transduced cells had significantly larger growth cones (33.12+/-1.06 microm(2)) than LV/GFP-pretreated cells (23.72+/-1.22 microm(2)).
CONCLUSION: These results indicate that blocking the RhoA/ROCK signaling pathway by expression of DNROCK is effective in facilitating neurite outgrowth in a microenvironment mimicking injury of central nervous system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383168      PMCID: PMC4002750          DOI: 10.1038/aps.2010.35

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  35 in total

1.  Inactivation of Rho signaling pathway promotes CNS axon regeneration.

Authors:  M Lehmann; A Fournier; I Selles-Navarro; P Dergham; A Sebok; N Leclerc; G Tigyi; L McKerracher
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

2.  Disinhibition of neurotrophin-induced dorsal root ganglion cell neurite outgrowth on CNS myelin by siRNA-mediated knockdown of NgR, p75NTR and Rho-A.

Authors:  Zubair Ahmed; Russell G Dent; Ellen L Suggate; Lee B Barrett; Ruth J Seabright; Martin Berry; Ann Logan
Journal:  Mol Cell Neurosci       Date:  2005-03       Impact factor: 4.314

Review 3.  Regulating axon growth within the postnatal central nervous system.

Authors:  Fenghua Hu; Stephen M Strittmatter
Journal:  Semin Perinatol       Date:  2004-12       Impact factor: 3.300

4.  Application of Rho antagonist to neuronal cell bodies promotes neurite growth in compartmented cultures and regeneration of retinal ganglion cell axons in the optic nerve of adult rats.

Authors:  Johanne Bertrand; Matthew J Winton; Nieves Rodriguez-Hernandez; Robert B Campenot; Lisa McKerracher
Journal:  J Neurosci       Date:  2005-02-02       Impact factor: 6.167

Review 5.  An emerging link between cytoskeletal dynamics and cell adhesion molecules in growth cone guidance.

Authors:  D M Suter; P Forscher
Journal:  Curr Opin Neurobiol       Date:  1998-02       Impact factor: 6.627

Review 6.  Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility.

Authors:  C D Nobes; A Hall
Journal:  Biochem Soc Trans       Date:  1995-08       Impact factor: 5.407

7.  Myosin II activation promotes neurite retraction during the action of Rho and Rho-kinase.

Authors:  M Amano; K Chihara; N Nakamura; Y Fukata; T Yano; M Shibata; M Ikebe; K Kaibuchi
Journal:  Genes Cells       Date:  1998-03       Impact factor: 1.891

8.  A third-generation lentivirus vector with a conditional packaging system.

Authors:  T Dull; R Zufferey; M Kelly; R J Mandel; M Nguyen; D Trono; L Naldini
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo.

Authors:  Ying Gao; Kangwen Deng; Jianwei Hou; J Barney Bryson; Angel Barco; Elena Nikulina; Tim Spencer; Wilfredo Mellado; Eric R Kandel; Marie T Filbin
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

10.  A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration.

Authors:  G Mukhopadhyay; P Doherty; F S Walsh; P R Crocker; M T Filbin
Journal:  Neuron       Date:  1994-09       Impact factor: 17.173

View more
  7 in total

1.  Lentiviral vector mediates exogenous gene expression in adult rat DRG following peripheral nerve remote delivery.

Authors:  Ping Yang
Journal:  J Mol Neurosci       Date:  2012-02-09       Impact factor: 3.444

2.  The effect of rho kinase inhibition on morphological and electrophysiological maturity in iPSC-derived neurons.

Authors:  Lise J Harbom; Taylor L Rudisill; Nadine Michel; Karen A Litwa; Mark P Beenhakker; Michael J McConnell
Journal:  Cell Tissue Res       Date:  2018-11-08       Impact factor: 5.249

Review 3.  Exploring the therapeutic promise of targeting Rho kinase in rheumatoid arthritis.

Authors:  Anuja Singh; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Vasudevan Mani; Amal M Alsubayiel; Saurabh Bhatia; Ahmed Al-Harrasi; Simona Bungau
Journal:  Inflammopharmacology       Date:  2021-10-26       Impact factor: 4.473

4.  Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy.

Authors:  Rosa Simona Pinca; Maria Cristina Manara; Valentina Chiadini; Piero Picci; Cinzia Zucchini; Katia Scotlandi
Journal:  Oncol Rep       Date:  2017-01-20       Impact factor: 3.906

5.  The protocadherin alpha cluster is required for axon extension and myelination in the developing central nervous system.

Authors:  Wen-Cheng Lu; Yu-Xiao Zhou; Ping Qiao; Jin Zheng; Qiang Wu; Qiang Shen
Journal:  Neural Regen Res       Date:  2018-03       Impact factor: 5.135

6.  Tackling obstacles for gene therapy targeting neurons: disrupting perineural nets with hyaluronidase improves transduction.

Authors:  Klaus Wanisch; Stjepana Kovac; Stephanie Schorge
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

Review 7.  The role of the Rho/ROCK signaling pathway in inhibiting axonal regeneration in the central nervous system.

Authors:  Jing Liu; Hong-Yan Gao; Xiao-Feng Wang
Journal:  Neural Regen Res       Date:  2015-11       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.